Updated results from CARTITUDE-1: Phase 1b/2study of ciltacabtagene autoleucel, a B-cell maturation antigendirected chimeric antigen receptor T cell therapy, in patients with relapsed/refractory multiple myeloma Meeting Abstract
| Authors: | Martin, T.; Usmani, S. Z.; Berdeja, J. G.; Jakubowiak, A.; Agha, M.; Cohen, A. D.; Hari, P.; Avigan, D.; Deol, A.; Htut, M.; Lesokhin, A.; Munshi, N. C.; O'Donnell, E.; Stewart, A. K.; Schecter, J. M.; Goldberg, J. D.; Jackson, C. C.; Yeh, T. M.; Banerjee, A.; Allred, A.; Zudaire, E.; Deraedt, W.; Madduri, D.; Olyslager, Y.; Zhou, C.; Pacaud, L.; Lin, Y.; Jagannath, S. |
| Abstract Title: | Updated results from CARTITUDE-1: Phase 1b/2study of ciltacabtagene autoleucel, a B-cell maturation antigendirected chimeric antigen receptor T cell therapy, in patients with relapsed/refractory multiple myeloma |
| Meeting Title: | 63rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736398802090 |
| DOI: | 10.1182/blood-2021-146060 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 549 -- Hybrid meeting, also took place online -- Source: Wos |
